NovoCure reports 'positive' results from its STELLAR phase 2 pilot trial in mesothelioma
- The data showed clinically meaningful improvements in overall survival and progression free survival among patients who received Tumor Treating Fields plus standard of care chemotherapy, pemetrexed and cisplatin or carboplatin, compared to historical control data of patients who received standard of care chemotherapy alone.
- Novocure will submit the full data for presentation at an upcoming medical conference.
- These results are preliminary top-line data and are subject to further analysis.
No comments:
Post a Comment